SCHEMBL3792205

SCHEMBL3792205

CCSc1cccc(-c2ccc(N)cc2)c1N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 2/20 0.35
KDR P35968 2/20 0.35
FLT3 P36888 2/20 0.35
NPC1 O15118 1/20 0.35
ATM Q13315 1/20 0.35
HTR7 P34969 2/20 0.34
ATR Q13535 1/20 0.34
CYP3A4 P08684 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
ALDH1A1 P00352 2/20 0.33
TAAR1 Q96RJ0 2/20 0.33
TP53 P04637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BCHE P06276 1/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 2/20 0.32
GAA P10253 2/20 0.32
GLA P06280 1/20 0.32
HTT P42858 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3789786 0.88 HTR7 (0.45) KDRNPC1ATMHTR7ATR
SCHEMBL3789854 0.86 HTR7 (0.46) NPC1ATMHTR7ATRCYP3A4
SCHEMBL3788519 0.83 MAP4K4 (0.42) ATRCYP3A4ALDH1A1TP53KDM4E
SCHEMBL3787018 0.80 KDR (0.38) KITKDRFLT3NPC1CYP3A4
SCHEMBL3787227 0.77 ALDH1A1 (0.46) NPC1ATMHTR7ATRALDH1A1
SCHEMBL3791267 0.76 MEN1 (0.35) CYP3A4TDP1ALDH1A1TAAR1TP53
SCHEMBL3802944 0.76 RECQL (0.35) KITKDRFLT3CYP3A4TDP1
SCHEMBL3785152 0.75 CNR1 (0.36) NPC1ATMCYP3A4TDP1ALDH1A1
SCHEMBL3787049 0.75 TDP1 (0.36) NPC1CYP3A4TDP1ALDH1A1TAAR1
SCHEMBL3785271 0.72 HPGD (0.46) KITKDRFLT3CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 KIT 605/4885KDR 1921/4885FLT3 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.